![]() | |
Type | Public |
---|---|
| |
Industry | Pharmaceutical (animal) |
Founded | 1954 ![]() |
Headquarters | Greenfield, Indiana, U.S. |
Key people |
|
Products | Pharmaceutical drugs (animal) |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 10,200 (2021) [2] |
Website | elanco |
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. [3]
The company traces its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division led by George Barnes. In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company. [4]
In the 1980s research moved away from plant sciences and focused on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health. [4]
In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International. In 2009 the business launched its data analytics business, Elanco Knowledge Solutions. [4]
In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site. [5] In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health. [6] In 2012 the business acquired ChemGen Corp. [7] In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum [8] and Novartis Animal Health for $5.4 billion. In 2016 Elanco expanded its US-based business, acquiring vaccines from Boehringer Ingelheim Vetmedica for $885 million. [9]
In 2013, Elanco made a $100M investment in China Animal Healthcare. [10]
In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ELAN. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved rabacfosadine, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics, [11] and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc. [12] In the same year the business announced it would acquire Bayer's animal health business for $7.6 billion. [13] [14]
On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021. [15] [ needs update ]
In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences. [16]
Elanco's flea and tick collar, branded "Seresto," which was developed by Bayer Animal Health and acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars are not registered for sale in Canada. [17] [18]
On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause for reported animal deaths. The EPA limited the collar's registration to five years instead of the normal fifteen years registration, as other pesticides normally receive. Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data. [19]
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
The Takeda Pharmaceutical Company Limited[takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.
Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and merged with Boehringer Ingelheim's existing animal health assets.
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
Inovalon is an American technology company that provides cloud-based tools for healthcare.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee. CureVac has approximately 375 employees since May 2018.
Olivier Brandicourt is a French business executive and physician, and the former chief executive officer of Sanofi.
Cancer Breakthroughs 2020, also known as Cancer Moonshot 2020 is a coalition with the goal of finding vaccine-based immunotherapies against cancer. By pooling the resources of multinational pharmaceutical, biotechnology companies, academic centers and oncologists, it intends to create access to over 60 novel and approved agents under exploration in the war against cancer and is expected to enable rapid testing of novel immunotherapy combination protocols. The initiative is being managed by a consortium of companies called The National Immunotherapy Coalition.
Woodruff, previously known as Woodruff Sweitzer, is an advertising agency founded in Columbia, Missouri by Terry Woodruff. Woodruff has worked with various national and regional clients including Bayer HealthCare's Animal Health Division, Arysta LifeScience Corp, Diamond Pet Foods, Missouri Farm Bureau Insurance, and the University of Missouri's Athletics Department. In 2007, Woodruff was selected to produce Boone County National Bank's 150th anniversary campaign, which led to Woodruff working with its parent company, Central Bancompany.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.